These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. PART1 facilitates tumorigenesis and inhibits ferroptosis by regulating the miR-490-3p/SLC7A11 axis in hepatocellular carcinoma. Li D; Wan M; Liu X; Ojha SC; Sheng Y; Li Y; Sun C; Deng C Aging (Albany NY); 2024 Jul; 16(14):11339-11358. PubMed ID: 39029955 [TBL] [Abstract][Full Text] [Related]
3. Analysis and Validation of Human Targets and Treatments Using a Hepatocellular Carcinoma-Immune Humanized Mouse Model. Zhao Y; Wang J; Liu WN; Fong SY; Shuen TWH; Liu M; Harden S; Tan SY; Cheng JY; Tan WWS; Chan JKY; Chee CE; Lee GH; Toh HC; Lim SG; Wan Y; Chen Q Hepatology; 2021 Sep; 74(3):1395-1410. PubMed ID: 33738839 [TBL] [Abstract][Full Text] [Related]
4. RNA binding protein DAZAP1 promotes HCC progression and regulates ferroptosis by interacting with SLC7A11 mRNA. Wang Q; Guo Y; Wang W; Liu B; Yang G; Xu Z; Li J; Liu Z Exp Cell Res; 2021 Feb; 399(1):112453. PubMed ID: 33358859 [TBL] [Abstract][Full Text] [Related]
5. Exosome-derived circUPF2 enhances resistance to targeted therapy by redeploying ferroptosis sensitivity in hepatocellular carcinoma. Dong FL; Xu ZZ; Wang YQ; Li T; Wang X; Li J J Nanobiotechnology; 2024 May; 22(1):298. PubMed ID: 38811968 [TBL] [Abstract][Full Text] [Related]
7. Identification of SLC7A11-AS1/SLC7A11 pair as a ferroptosis-related therapeutic target for hepatocellular carcinoma. Yuan X; Wang Y; Jiao S; Gao H; Zhang M; Wang X; Zhou X; Wu C; Bao J J Cell Mol Med; 2024 Jul; 28(13):e18496. PubMed ID: 38984939 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing. Hao X; Zheng Z; Liu H; Zhang Y; Kang J; Kong X; Rong D; Sun G; Sun G; Liu L; Yu H; Tang W; Wang X Redox Biol; 2022 Oct; 56():102463. PubMed ID: 36108528 [TBL] [Abstract][Full Text] [Related]
9. Curcumin promotes ferroptosis in hepatocellular carcinoma via upregulation of ACSL4. Jiang Y; Hui D; Pan Z; Yu Y; Liu L; Yu X; Wu C; Sun M J Cancer Res Clin Oncol; 2024 Sep; 150(9):429. PubMed ID: 39311951 [TBL] [Abstract][Full Text] [Related]
11. IL-1β-Induced Elevation of Solute Carrier Family 7 Member 11 Promotes Hepatocellular Carcinoma Metastasis Through Up-regulating Programmed Death Ligand 1 and Colony-Stimulating Factor 1. He Q; Liu M; Huang W; Chen X; Zhang B; Zhang T; Wang Y; Liu D; Xie M; Ji X; Sun M; Tian D; Xia L Hepatology; 2021 Dec; 74(6):3174-3193. PubMed ID: 34288020 [TBL] [Abstract][Full Text] [Related]
12. CD8 Wang W; Green M; Choi JE; Gijón M; Kennedy PD; Johnson JK; Liao P; Lang X; Kryczek I; Sell A; Xia H; Zhou J; Li G; Li J; Li W; Wei S; Vatan L; Zhang H; Szeliga W; Gu W; Liu R; Lawrence TS; Lamb C; Tanno Y; Cieslik M; Stone E; Georgiou G; Chan TA; Chinnaiyan A; Zou W Nature; 2019 May; 569(7755):270-274. PubMed ID: 31043744 [TBL] [Abstract][Full Text] [Related]
13. Synergistic activity of Yu H; Lin G; Jiang J; Yao J; Pan Z; Xie H; Bo Z; He Q; Yang J; Chen Z; Li J; Wang Y; Yu Z; Assaraf YG; Chen G Gut Microbes; 2024; 16(1):2410474. PubMed ID: 39353096 [TBL] [Abstract][Full Text] [Related]
14. APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Du Y; Zhou Y; Yan X; Pan F; He L; Guo Z; Hu Z Cell Death Differ; 2024 Apr; 31(4):431-446. PubMed ID: 38418695 [TBL] [Abstract][Full Text] [Related]
15. IFNγ-mediated repression of system xc Kong R; Wang N; Han W; Bao W; Lu J J Leukoc Biol; 2021 Aug; 110(2):301-314. PubMed ID: 34318944 [TBL] [Abstract][Full Text] [Related]
16. Aspirin triggers ferroptosis in hepatocellular carcinoma cells through restricting NF-κB p65-activated SLC7A11 transcription. Wang YF; Feng JY; Zhao LN; Zhao M; Wei XF; Geng Y; Yuan HF; Hou CY; Zhang HH; Wang GW; Yang G; Zhang XD Acta Pharmacol Sin; 2023 Aug; 44(8):1712-1724. PubMed ID: 36829052 [TBL] [Abstract][Full Text] [Related]
17. ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis. He F; Zhang P; Liu J; Wang R; Kaufman RJ; Yaden BC; Karin M J Hepatol; 2023 Aug; 79(2):362-377. PubMed ID: 36996941 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-7 enhances anti-tumor activity of CD8 Teng D; Ding L; Cai B; Luo Q; Wang H Cytokine; 2019 Jun; 118():115-123. PubMed ID: 29655570 [TBL] [Abstract][Full Text] [Related]
19. Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice. Chiu DK; Yuen VW; Cheu JW; Wei LL; Ting V; Fehlings M; Sumatoh H; Nardin A; Newell EW; Ng IO; Yau TC; Wong CM; Wong CC Gastroenterology; 2020 Aug; 159(2):609-623. PubMed ID: 32275969 [TBL] [Abstract][Full Text] [Related]
20. Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylation. Shi Z; Li Z; Jin B; Ye W; Wang L; Zhang S; Zheng J; Lin Z; Chen B; Liu F; Zhang B; Ding X; Yang Z; Shan Y; Yu Z; Wang Y; Chen J; Chen Q; Roberts LR; Chen G Clin Transl Med; 2023 Jun; 13(6):e1300. PubMed ID: 37337470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]